Wang H Y, Wang F, Cheng M, Liu Y, Zhang S Y
Institute of Harbin Haematology and Oncology, Harbin First Hospital,Harbin,People's Republic of China.
Research Center of the Second Affiliated Hospital of Harbin Medical University,Harbin,People's Republic of China.
Epidemiol Infect. 2015 Oct;143(13):2805-12. doi: 10.1017/S0950268814003902. Epub 2015 Jan 16.
This study investigated clinical implications of human leukocyte antigen (HLA) I and II haplotypes, in combination with HBV sub-genotype C2, in hepatitis B virus (HBV) infections in northeastern China. Here, HLA haplotypes of 230 HBV-infected patients were compared to 210 healthy, unrelated Han individuals. Of the 230 HBV-infected patients, 54 had acute self-limited hepatitis (ASH) with sub-genotype C2 (ASH-C2), 144 had chronic hepatitis (CH) with sub-genotypes C2 and B2 (CH-C2 and CH-B2), and 32 spontaneously recovered without sub-genotype results. All groups underwent HLA typing and haplotype analysis. The results revealed that A02-DRB112 and A02-B15-DRB109 carriers were susceptible to HBV infection. A02-B15-DRB109 is probably associated with acute onset and viral clearance and A02-DRB112, with viral persistence. In HBV infections, B40-DRB112 was associated with HBV persistence, whereas B46-DRB109, A24-DRB114, and B15-DRB104 carriers easily recovered from the disease. By contrast, when infected with the HBV-C2 sub-genotype, A24-DRB114, B15-DRB104, A02-B15, A02-DRB115, and A02-B15-DRB1*09 carriers displayed an acute clinical course before recovery. This study reveals a relationship between HLA haplotypes and HBV pathogenesis, thereby providing potential therapeutic targets to treat HBV infection.
本研究调查了人类白细胞抗原(HLA)I和II单倍型与乙肝病毒(HBV)C2亚基因型相结合,在中国东北地区HBV感染中的临床意义。在此,将230例HBV感染患者的HLA单倍型与210名健康、无亲缘关系的汉族个体进行了比较。在230例HBV感染患者中,54例患有C2亚基因型急性自限性肝炎(ASH)(ASH-C2),144例患有C2和B2亚基因型慢性肝炎(CH)(CH-C2和CH-B2),32例自发康复但无亚基因型检测结果。所有组均进行了HLA分型和单倍型分析。结果显示,A02-DRB112和A02-B15-DRB109携带者易感染HBV。A02-B15-DRB109可能与急性发病和病毒清除有关,而A02-DRB112与病毒持续存在有关。在HBV感染中,B40-DRB112与HBV持续存在有关,而B46-DRB109、A24-DRB114和B15-DRB104携带者易从疾病中康复。相比之下,当感染HBV-C2亚基因型时,A24-DRB114、B15-DRB104、A02-B15、A02-DRB115和A02-B15-DRB1*09携带者在康复前表现出急性临床病程。本研究揭示了HLA单倍型与HBV发病机制之间的关系,从而为治疗HBV感染提供了潜在的治疗靶点。